Alpha Cognition Inc. Common Stock ACOG
Set alert
At close · Oct 30
After hours · Oct 30, 4:00 PM ET
- YTD
- +34.46%
- 1 year
- +41.42%
- Open
- 9.06
- Prev close
- 9.19
- Mkt cap
- 190.34M
- Vol
- 48.32K
- Avg vol
- 122.99K
- EPS
- -1.32
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 8.72
- High
- 9.17
- Forward P/E
- 0.00
- Beta
- 0.00
- Dividend
- 0.00
- Ex-div date
- 50-d avg
- 5.66
- 200-d avg
- 5.66
- 1y target
- 0.00
News
2 weeks ago businesswire.com
Alpha Cognition Announces Publication of U.S. Patent Application Relating to Proprietary Manufacturing Process for ZUNVEYL®
VANCOUVER, British Columbia & GRAPEVINE, Texas--(BUSINESS WIRE)--Alpha Cognition Inc. (NASDAQ: ACOG) ("Alpha Cognition" or the "Company"), a biopharmaceutical company developing and commercializing…
3 weeks ago defenseworld.net
Alpha Cognition Inc. (NASDAQ:ACOG) Receives Average Recommendation of “Buy” from Brokerages
Shares of Alpha Cognition Inc. (NASDAQ: ACOG - Get Free Report) have earned a consensus rating of "Buy" from the five brokerages that are covering the stock, Marketbeat reports. Five investment…
3 weeks ago businesswire.com
Alpha Cognition to Present New ZUNVEYL® (Benzgalantamine) Clinical and Real-World Data at ASCP Annual Meeting and NEI Fall Congress
VANCOUVER, British Columbia & DALLAS--(BUSINESS WIRE)--Alpha Cognition Inc. (Nasdaq: ACOG) (“Alpha Cognition” or the “Company”), a commercial-stage biopharmaceutical company focused on developing…
1 month ago businesswire.com
Alpha Cognition Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
VANCOUVER, British Columbia & GRAPEVINE, Texas--(BUSINESS WIRE)--Alpha Cognition Inc. (NASDAQ: ACOG) (“Alpha Cognition”, “ACI”, or the “Company”), a biopharmaceutical company developing novel…
-
1 month ago benzinga.com
Alpha Cognition Announces Data From Its 180-Day Analysis Of Its CONVERGE PRogram For Patients Receiving ZUNVEYL, Donepezil, Galantamine Or Rivastigmine
Alpha Cognition Inc. (NASDAQ: ACOG) ("Alpha Cognition," "ACI," or the "Company") today announced initial results from CONVERGE, an ongoing retrospective real-world evidence evaluation using
1 month ago businesswire.com
Alpha Cognition Announces CONVERGE Real-World Evidence on ZUNVEYL®(Benzgalantamine) Use in Long-Term Care
VANCOUVER, British Columbia & GRAPEVINE, Texas--(BUSINESS WIRE)--Alpha Cognition Inc. (NASDAQ: ACOG) ("Alpha Cognition," "ACI," or the "Company") today announced initial results from CONVERGE, an…
1 month ago defenseworld.net
Reviewing Alpha Cognition (NASDAQ:ACOG) & Karyopharm Therapeutics (NASDAQ:KPTI)
Karyopharm Therapeutics (NASDAQ: KPTI - Get Free Report) and Alpha Cognition (NASDAQ: ACOG - Get Free Report) are both small-cap healthcare companies, but which is the better business? We will…
1 month ago defenseworld.net
Analysts Set Alpha Cognition Inc. (NASDAQ:ACOG) Target Price at $18.00
Alpha Cognition Inc. (NASDAQ: ACOG - Get Free Report) has received an average rating of "Buy" from the five analysts that are presently covering the firm, Marketbeat.com reports. Five investment…
1 month ago businesswire.com
Alpha Cognition Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
VANCOUVER, British Columbia & GRAPEVINE, Texas--(BUSINESS WIRE)--Alpha Cognition Inc. (NASDAQ: ACOG) (“Alpha Cognition”, “ACI”, or the “Company”), a biopharmaceutical company developing novel…
2 months ago businesswire.com
Alpha Cognition Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
VANCOUVER, British Columbia & GRAPEVINE, Texas--(BUSINESS WIRE)--Alpha Cognition Inc. (NASDAQ: ACOG) (“Alpha Cognition”, “ACI”, or the “Company”), a biopharmaceutical company developing novel…
2 months ago benzinga.com
This Sphere Entertainment Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Thursday
Top Wall Street analysts updated ratings on SPHR, CVLG, MIST, MSGE,. Check out analyst ratings page for full details and stock recommendations.
-
2 months ago benzinga.com
B. Riley Securities Initiates Coverage On Alpha Cognition with Buy Rating, Announces Price Target of $21
B. Riley Securities analyst William Woods initiates coverage on Alpha Cognition (NASDAQ:ACOG) with a Buy rating and announces Price Target of $21.
-
2 months ago benzinga.com
HC Wainwright & Co. Maintains Buy on Alpha Cognition, Raises Price Target to $20
HC Wainwright & Co. analyst Raghuram Selvaraju maintains Alpha Cognition (NASDAQ:ACOG) with a Buy and raises the price target from $18 to $20.
2 months ago newsfilecorp.com
Stonegate Capital Partners Updates Coverage on Alpha Cognition Inc. (ACOG) 2Q26
Dallas, Texas--(Newsfile Corp. - August 17, 2026) - Alpha Cognition Inc. (NASDAQ: ACOG): Stonegate Capital Partners updates their coverage on Alpha Cognition Inc. (NASDAQ: ACOG). Alpha Cognition's…
2 months ago seekingalpha.com
Alpha Cognition Inc. (ACOG) Q2 2026 Earnings Call Transcript
Alpha Cognition Inc. (ACOG) Q2 2026 Earnings Call Transcript
2 months ago zacks.com
Alpha Cognition Inc. (ACOG) Reports Q2 Loss, Tops Revenue Estimates
Alpha Cognition Inc. (ACOG) came out with a quarterly loss of $0.4 per share versus the Zacks Consensus Estimate of a loss of $0.39. This compares to a loss of $0.65 per share a year ago.
2 months ago marketbeat.com
Alpha Cognition Q2 Earnings Call Highlights
Alpha Cognition NASDAQ: ACOG reported second-quarter 2026 net product revenue of approximately $6 million from its Alzheimer's treatment ZUNVEYL, up about 71% sequentially from $3.5 million in the…
2 months ago benzinga.com
Alpha Cognition Q2 2026 Earnings Call Transcript
Alpha Cognition (NASDAQ:ACOG) reported second-quarter financial results on Thursday. The transcript from the company's second-quarter earnings call has been provided below. This content is powered by…
-
2 months ago benzinga.com
Alpha Cognition Q2 EPS $(0.40) Misses $(0.39) Estimate, Sales $6.092M Beat $4.384M Estimate
Alpha Cognition (NASDAQ:ACOG) reported quarterly losses of $(0.40) per share which missed the analyst consensus estimate of $(0.39) by 2.56 percent. This is a 38.46 percent increase over losses of…
2 months ago businesswire.com
Alpha Cognition Inc. Reports Second Quarter 2026 Financial Results and Provides Operational Update
VANCOUVER, British Columbia & DALLAS--(BUSINESS WIRE)--Alpha Cognition Inc. (NASDAQ: ACOG) (“Alpha Cognition”, “ACI”, or the “Company”), a biopharmaceutical company developing novel therapeutics for…
2 months ago zacks.com
Alpha Cognition Inc. (ACOG) Expected to Beat Earnings Estimates: What to Know Ahead of Q2 Release
Alpha Cognition Inc. (ACOG) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
3 months ago businesswire.com
Alpha Cognition to Report Second Quarter 2026 Financial Results and Provide Business Update
VANCOUVER, British Columbia & DALLAS--(BUSINESS WIRE)--Alpha Cognition Inc. (Nasdaq: ACOG), a biopharmaceutical company dedicated to advancing treatments for neurodegenerative diseases, today…
3 months ago businesswire.com
Alpha Cognition Receives European Patent Covering ZUNVEYL® for the Treatment of Mild-to-Moderate Alzheimer's Disease
VANCOUVER, British Columbia & GRAPEVINE, Texas--(BUSINESS WIRE)--Alpha Cognition Inc. (NASDAQ: ACOG) (“Alpha Cognition” (ACI), or the “Company”), a biopharmaceutical company developing novel…
3 months ago zacks.com
Alpha Cognition Inc. (ACOG) Surges 8.6%: Is This an Indication of Further Gains?
Alpha Cognition Inc. (ACOG) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further…
3 months ago seekingalpha.com
Playing The Biotech Breakout With Insiders
Biotech stocks are consolidating after a breakout, with bullish insider Wall Street sentiment. AbCellera Biologics and Alpha Cognition stand out for insider buying, revenue growth, and high Seeking…
3 months ago businesswire.com
Alpha Cognition to Participate in Panel Discussion at the B. Riley Securities Mind, Muscle & Vision Summit
VANCOUVER, British Columbia & DALLAS--(BUSINESS WIRE)--Alpha Cognition Inc. (Nasdaq: ACOG) (“Alpha Cognition”, or the “Company”), a biopharmaceutical company focused on developing novel therapies for…
3 months ago benzinga.com
This Travelers Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Friday
Wall Street analysts changed outlook on top names. See all changes on analyst ratings page. Consider buying TRV stock, analysts have Buy rating.
-
3 months ago benzinga.com
Raymond James Initiates Coverage On Alpha Cognition with Outperform Rating, Announces Price Target of $20
Raymond James analyst Ryan Deschner initiates coverage on Alpha Cognition (NASDAQ:ACOG) with a Outperform rating and announces Price Target of $20.
-
4 months ago benzinga.com
Alpha Cognition Appoints Robert Wills As Board Chairman, Succeeding Len Mertz
Alpha Cognition Inc. (Nasdaq: ACOG) ("Alpha Cognition", or the "Company"), a biopharmaceutical company focused on developing novel therapies for debilitating neurodegenerative disorders, today…
-
4 months ago benzinga.com
Alpha Cognition Enrolls First Patient In RESOLVE, Phase 4 Post-Marketing Clinical Study To Further Evaluate Tolerability Profile, Treatment Experience Associated With ZUNVEYL In Routine Clinical Practice
Alpha Cognition, Inc. (ACOG: NASDAQ) ("Alpha Cognition" or the "Company"), a biopharmaceutical company dedicated to developing innovative therapies for neurodegenerative diseases, today announced the…
-
4 months ago benzinga.com
Alpha Cognition Reports Top-Line Results From BEACON Real-World Study Of ZUNVEYL
Providers reported cognitive improvement in 92% of patients following initiation of ZUNVEYLProviders reported improvement in neuropsychiatric symptoms in 93% of patients after initiation of…
5 months ago benzinga.com
12 Health Care Stocks Moving In Friday's After-Market Session
12 Health Care Stocks Moving In Friday's After-Market Session
-
5 months ago benzinga.com
Maxim Group Initiates Coverage On Alpha Cognition with Buy Rating, Announces Price Target of $12
Maxim Group analyst Naz Rahman initiates coverage on Alpha Cognition (NASDAQ:ACOG) with a Buy rating and announces Price Target of $12.
5 months ago benzinga.com
12 Health Care Stocks Moving In Thursday's Pre-Market Session
12 Health Care Stocks Moving In Thursday's Pre-Market Session
-
5 months ago benzinga.com
HC Wainwright & Co. Reiterates Buy on Alpha Cognition, Maintains $18 Price Target
HC Wainwright & Co. analyst Raghuram Selvaraju reiterates Alpha Cognition (NASDAQ:ACOG) with a Buy and maintains $18 price target.
-
5 months ago benzinga.com
Full Transcript: Alpha Cognition Q1 2026 Earnings Call
Full Transcript: Alpha Cognition Q1 2026 Earnings Call
5 months ago benzinga.com
12 Health Care Stocks Moving In Thursday's After-Market Session
12 Health Care Stocks Moving In Thursday's After-Market Session
-
5 months ago benzinga.com
Alpha Cognition Q1 EPS $(0.32) Beats $(0.39) Estimate, Sales $3.534M Beat $3.423M Estimate
Alpha Cognition (NASDAQ:ACOG) reported quarterly losses of $(0.32) per share which beat the analyst consensus estimate of $(0.39) by 17.95 percent. This is a 146.15 percent decrease over losses of…
-
6 months ago benzinga.com
HC Wainwright & Co. Reiterates Buy on Alpha Cognition, Maintains $18 Price Target
HC Wainwright & Co. analyst Raghuram Selvaraju reiterates Alpha Cognition (NASDAQ:ACOG) with a Buy and maintains $18 price target.
-
6 months ago benzinga.com
Craig-Hallum Initiates Coverage On Alpha Cognition with Buy Rating, Announces Price Target of $14
Craig-Hallum analyst Chase Knickerbocker initiates coverage on Alpha Cognition (NASDAQ:ACOG) with a Buy rating and announces Price Target of $14.
-
7 months ago benzinga.com
12 Health Care Stocks Moving In Thursday's After-Market Session
12 Health Care Stocks Moving In Thursday's After-Market Session
-
7 months ago benzinga.com
Alpha Cognition Q4 EPS $(0.30) Misses $(0.27) Estimate, Sales $2.793M Miss $3.197M Estimate
Alpha Cognition (NASDAQ:ACOG) reported quarterly losses of $(0.30) per share which missed the analyst consensus estimate of $(0.27) by 11.11 percent. This is a 41.18 percent increase over losses of…
-
7 months ago benzinga.com
Earnings Scheduled For March 26, 2026
Earnings Scheduled For March 26, 2026
-
7 months ago benzinga.com
12 Health Care Stocks Moving In Thursday's After-Market Session
12 Health Care Stocks Moving In Thursday's After-Market Session
-
8 months ago benzinga.com
Alpha Cognition Enrolls First Participant In BEACON Trial To Evaluate ZUNVEYL
Alpha Cognition Inc. (NASDAQ: ACOG) ("Alpha Cognition," "ACI," or the "Company"), a clinical-stage biopharmaceutical company dedicated to developing innovative therapies for neurodegenerative…
-
8 months ago benzinga.com
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
-
9 months ago benzinga.com
Alpha Cognition Targets 2,000 ZUNVEYL Prescribers In 2026; Plans 3 Long-Term Care Alzheimer's Studies; Anticipates $3M Asia Licensing Milestone; Aims For Operating Profitability In 2027
ZUNVEYL prescriber base expected to expand to approximately 2,000 prescribing healthcare providers, and an increase in nursing home penetrationCompany expects to complete and/or initiate three…
-
10 months ago benzinga.com
HC Wainwright & Co. Reiterates Buy on Alpha Cognition, Maintains $18 Price Target
HC Wainwright & Co. analyst Raghuram Selvaraju reiterates Alpha Cognition (NASDAQ:ACOG) with a Buy and maintains $18 price target.
-
11 months ago benzinga.com
Earnings Scheduled For November 13, 2025
Earnings Scheduled For November 13, 2025